Evotec grows in Q3 but profit slips

Evotec AG, which provides discovery and development services to other pharmaceutical companies, continued to grow rapidly in the third quarter. This time the expansion was helped by the acquisition of Aptuit LLC, a US-based company that provides similar services, and the earlier takeover of Cyprotex Plc, a specialist UK contract research organisation. 

Full text available to subscribers only. Click here for information on subscribing to MedNous.